North China Pharmaceutical Company.Ltd

XSSC:600812 Stock Report

Market Cap: CN¥9.5b

North China Pharmaceutical Company.Ltd Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Xin Yan Liu

Chief executive officer

CN¥262.4k

Total compensation

CEO salary percentagen/a
CEO tenure3.3yrs
CEO ownershipn/a
Management average tenure3.3yrs
Board average tenure4.5yrs

Recent management updates

Recent updates


CEO

Xin Yan Liu (54 yo)

3.3yrs

Tenure

CN¥262,400

Compensation

Mr. Xin Yan Liu is General Manager and Director of North China Pharmaceutical Company Ltd. since August 13, 2021 and served as its Deputy General Manager.


Leadership Team

NamePositionTenureCompensationOwnership
Xin Yan Liu
GM & Director3.3yrsCN¥262.40kno data
Jianjun Li
CFO & Chief Accountant3.3yrsCN¥200.40kno data
Zhi Shan Chang
Deputy GM & Secretary8.7yrsCN¥200.40kno data

3.3yrs

Average Tenure

53yo

Average Age

Experienced Management: 600812's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Xin Yan Liu
GM & Director3.3yrsCN¥262.40kno data
Guangcheng Pan
Independent Director5.5yrsCN¥71.40kno data
Xiaohan Liu
Independent Director5.5yrsCN¥71.40kno data
Yao Cao
Director6.2yrsCN¥200.40kno data
Fan Li
Supervisor6.2yrsno datano data
Jigang Xie
Independent Director3.6yrsCN¥71.40kno data
Demin Zhou
Independent Director5.5yrsCN¥71.40kno data
Rentao Song
Director1.7yrsno datano data
Wei Lv
Chairman of the Supervisory Board2.1yrsno datano data
Wenzan Gao
Supervisor2.1yrsno datano data

4.5yrs

Average Tenure

55yo

Average Age

Experienced Board: 600812's board of directors are considered experienced (4.5 years average tenure).